Piper Jaffray raised its price target for Incyte Corporation (NASDAQ:INCY) to $121 citing the company’s “evolving” pipeline following its analyst event. Piper notes the company will present data at ASCO for its combination JAK1/PI3K inhibitors for treatment of B-cell malignancies and is talking to the FDA regarding a pivotal trialRead More

Newmont Mining (NEM) climbed Monday, buoyed by a positive Barron’s report that said shares of the mining firm could rise to $34, approximately 55% above last week’s trading price, as the firm has sold assets and cut costs to reduce its break-even gold production price. As the price of goldRead More